Total Payments
$974.04
2024 Payments
$244.69
Companies
16
Transactions
53
Medicare Patients
2,321
Medicare Billing
$319,352
Payment Breakdown by Category
Food & Beverage$964.43 (99.0%)
Education$9.61 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $964.43 | 49 | 99.0% |
| Education | $9.61 | 4 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $250.89 | 13 | $0 (2024) |
| PFIZER INC. | $130.85 | 8 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $117.05 | 6 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $102.48 | 5 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $69.66 | 3 | $0 (2024) |
| Lexicon Pharmaceuticals, Inc. | $45.92 | 2 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $44.82 | 2 | $0 (2024) |
| PORTOLA PHARMACEUTICALS, INC. | $41.89 | 2 | $0 (2019) |
| Inari Medical, Inc. | $32.22 | 1 | $0 (2024) |
| Gilead Sciences, Inc. | $31.64 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $244.69 | 13 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($47.52) |
| 2023 | $211.05 | 12 | E.R. Squibb & Sons, L.L.C. ($51.95) |
| 2022 | $154.00 | 8 | Janssen Pharmaceuticals, Inc ($79.81) |
| 2021 | $55.35 | 3 | E.R. Squibb & Sons, L.L.C. ($21.88) |
| 2020 | $29.10 | 2 | PFIZER INC. ($29.10) |
| 2019 | $77.89 | 4 | PORTOLA PHARMACEUTICALS, INC. ($41.89) |
| 2018 | $149.60 | 8 | Janssen Pharmaceuticals, Inc ($61.63) |
| 2017 | $52.36 | 3 | Janssen Pharmaceuticals, Inc ($23.38) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Gastroenterology | ||||||
| 08/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: DIABETES | ||||||
| 07/26/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 05/15/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 05/15/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 04/25/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $32.22 | General |
| Category: VTE | ||||||
| 04/18/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/08/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: DIABETES | ||||||
| 02/29/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Gastroenterology | ||||||
| 02/23/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 01/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/08/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 11/15/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: COVID-19 | ||||||
| 10/24/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 09/27/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/30/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.07 | General |
| Category: Cardiovascular | ||||||
| 08/30/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.31 | General |
| Category: Cardiovascular | ||||||
| 08/09/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Gastroenterology | ||||||
| 07/19/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/09/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: COVID-19 | ||||||
| 02/14/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.57 | General |
| Category: Cardiovascular | ||||||
| 01/19/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 420 | 689 | $271,416 | $63,565 |
| 2022 | 7 | 577 | 942 | $355,113 | $76,809 |
| 2021 | 7 | 586 | 934 | $365,777 | $80,737 |
| 2020 | 7 | 738 | 1,053 | $432,495 | $98,241 |
Total Patients
2,321
Total Services
3,618
Medicare Billing
$319,352
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 159 | 396 | $140,580 | $35,695 | 25.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 132 | 135 | $49,410 | $11,569 | 23.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 72 | 72 | $49,752 | $9,178 | 18.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 40 | 66 | $16,434 | $3,915 | 23.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 17 | 20 | $15,240 | $3,207 | 21.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 226 | 535 | $189,925 | $41,332 | 21.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 171 | 173 | $63,318 | $13,660 | 21.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 51 | 51 | $35,241 | $7,488 | 21.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 65 | 113 | $28,137 | $6,003 | 21.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 23 | 29 | $22,098 | $4,849 | 21.9% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $10,144 | $2,180 | 21.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 25 | 25 | $6,250 | $1,297 | 20.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 203 | 507 | $179,985 | $40,124 | 22.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 170 | 174 | $63,684 | $13,982 | 22.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 87 | 89 | $61,499 | $13,597 | 22.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 68 | 103 | $25,647 | $5,641 | 22.0% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 26 | 26 | $16,484 | $3,571 | 21.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 16 | 19 | $14,478 | $2,940 | 20.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 16 | 16 | $4,000 | $882.56 | 22.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 257 | 531 | $188,505 | $43,137 | 22.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 134 | 136 | $93,976 | $21,432 | 22.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 189 | 194 | $71,004 | $15,976 | 22.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 26 | 36 | $27,432 | $6,314 | 23.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 70 | 94 | $23,406 | $5,209 | 22.3% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 33 | 33 | $20,922 | $4,587 | 21.9% |
About Dr. Monisha Garg, M.D
Dr. Monisha Garg, M.D is a Nephrology healthcare provider based in Athens, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1710106141.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Monisha Garg, M.D has received a total of $974.04 in payments from pharmaceutical and medical device companies, with $244.69 received in 2024. These payments were reported across 53 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($964.43).
As a Medicare-enrolled provider, Garg has provided services to 2,321 Medicare beneficiaries, totaling 3,618 services with total Medicare billing of $319,352. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Hospitalist
- Location Athens, GA
- Active Since 04/24/2007
- Last Updated 06/13/2018
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1710106141
Products in Payments
- XARELTO (Drug) $250.89
- ELIQUIS (Drug) $105.79
- CAMZYOS (Drug) $77.40
- ENTRESTO (Drug) $77.02
- XIFAXAN (Drug) $69.66
- CHANTIX (Drug) $51.11
- Inpefa (Drug) $45.92
- JARDIANCE (Drug) $44.82
- ANDEXXA (Biological) $41.89
- FLOWTRIEVER CATHETER, S (Device) $32.22
- Veklury (Drug) $31.64
- LEQVIO (Drug) $25.46
- YUPELRI (Drug) $24.05
- IGALMI (Drug) $22.83
- LifeVest (Device) $17.37
- FARXIGA (Drug) $17.36
- RELISTOR (Drug) $15.40
- VYNDAMAX (Drug) $13.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Athens
Dr. Geoffrey Golembiewski, Md, MD
Nephrology — Payments: $5,952
Nephrology $5,952
Rene Mackay, M.d, M.D
Nephrology — Payments: $2,890
Nephrology $2,890
Dr. Abid Bashir, M.d, M.D
Nephrology — Payments: $2,319
Nephrology $2,319
Dr. Srilakshmi Rebala, M.d, M.D
Nephrology — Payments: $1,103
Nephrology $1,103
Kunal Bhuta
Nephrology — Payments: $456.16
Nephrology $456.16
Mr. Ashwin Thatti
Nephrology — Payments: $297.44
Nephrology $297.44